Beate Sander
Beate Sander
University Health Network
Verified email at
Cited by
Cited by
Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model
B Sander, A Nizam, LP Garrison Jr, MJ Postma, ME Halloran, ...
Value in Health 12 (2), 226-233, 2009
Modelling mitigation strategies for pandemic (H1N1) 2009
MZ Gojovic, B Sander, D Fisman, MD Krahn, CT Bauch
Cmaj 181 (10), 673-680, 2009
A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs
B Sander, V Elliot-Gibson, DE Beaton, ER Bogoch, A Maetzel
JBJS 90 (6), 1197-1205, 2008
Mega‐dose vitamin C in treatment of the common cold: a randomised controlled trial
C Audera, RV Patulny, BH Sander, RM Douglas
Medical journal of Australia 175 (7), 359-362, 2001
Mega‐dose vitamin C in treatment of the common cold: a randomised controlled trial
C Audera, RV Patulny, BH Sander, RM Douglas
Medical journal of Australia 175 (7), 359-362, 2001
Preventing pressure ulcers in long-term care: a cost-effectiveness analysis
A Stern, W Chen, B Sander, A John-Baptiste, HH Thein, T Gomes, ...
Archives of internal medicine 171 (20), 1839-1847, 2011
Economic burden of obesity and its complications in Germany
B Sander, R Bergemann
The European Journal of Health Economics, formerly: HEPAC 4 (4), 248-253, 2003
The economic impact of Clostridium difficile infection: a systematic review
N Nanwa, T Kendzerska, M Krahn, JC Kwong, N Daneman, W Witteman, ...
American Journal of Gastroenterology 110 (4), 511-519, 2015
Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis
B Sander, JC Kwong, CT Bauch, A Maetzel, A McGeer, JM Raboud, ...
PLoS Med 7 (4), e1000256, 2010
Human pathogens associated with the blacklegged tick Ixodes scapularis: a systematic review
MP Nelder, CB Russell, NJ Sheehan, B Sander, S Moore, Y Li, S Johnson, ...
Parasites & vectors 9 (1), 265, 2016
Long-term sequelae of West Nile virus-related illness: a systematic review
H Patel, B Sander, MP Nelder
The Lancet Infectious Diseases 15 (8), 951-959, 2015
The cost-effectiveness of pneumococcal conjugate vaccination in Australia
JRG Butler, P McIntyre, CR MacIntyre, R Gilmour, AL Howarth, B Sander
Vaccine 22 (9-10), 1138-1149, 2004
Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience
B Sander, CT Bauch, D Fisman, RA Fowler, JC Kwong, A Maetzel, ...
Vaccine 28 (38), 6210-6220, 2010
Reactive strategies for containing developing outbreaks of pandemic influenza
S Andradóttir, W Chiu, D Goldsman, ML Lee, KL Tsui, B Sander, ...
BMC public health 11 (S1), S1, 2011
Systematic review of the cost-effectiveness of influenza immunization programs
EEK Ting, B Sander, WJ Ungar
Vaccine 35 (15), 1828-1843, 2017
Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada
HAT Tu, SL Deeks, SK Morris, L Strifler, N Crowcroft, FB Jamieson, ...
Vaccine, 5436-5446, 2014
Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States
SE Talbird, AJ Brogan, AP Winiarski, B Sander
American Journal of Health-System Pharmacy 66 (5), 469-480, 2009
Effect of influenza treatment with oseltamivir on health outcome and costs in otherwise healthy children
K Reisinger, G Greene, R Aultman, B Sander, M Gyldmark
Clinical drug investigation 24 (7), 395-407, 2004
Health‐related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review
MW Yeung, E Khoo, SK Brode, FB Jamieson, H Kamiya, JC Kwong, ...
Respirology 21 (6), 1015-1025, 2016
Pandemic influenza: modelling and public health perspectives
J Arino, C Bauch, F Brauer, SM Driedger, AL Greer, SM Moghadas, ...
Mathematical Biosciences & Engineering 8 (1), 1, 2011
The system can't perform the operation now. Try again later.
Articles 1–20